About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 242 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 242 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 242 trials

Active not recruitingA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseThis is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD…NCT07094516·Phoenix, Arizona and 72 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAlzheimer's Disease Neuroimaging Initiative 3Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD.NCT02854033·Birmingham, Alabama and 58 others

CompletedIdalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilTo establish efficacy of Idalopirdine as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).NCT02006641·Phoenix, Arizona and 161 others

TerminatedA Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 StudyThe purpose of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with mild-to-moderate Alzheimer's disease.NCT00809510·Phoenix, Arizona and 21 others

TerminatedStudy of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's DiseaseThe purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.NCT00704782·Phoenix, Arizona and 3 others

RecruitingA SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesThe goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible…NCT05877196·Phoenix, Arizona

CompletedStudy Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)To determine the safety and tolerability of multiple ascending fixed oral doses of SRA-333 in subjects with mild to moderate Alzheimer's disease.NCT00151333·Phoenix, Arizona and 2 others

CompletedOpen-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's DiseaseThis is an open-label extension to study 49653/461, to assess the long-term safety of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's…NCT00381238·Litchfield Park, Arizona and 6 others

CompletedAddressing Dementia Via Agitation-Centered EvaluationThis is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's…NCT03226522·Gilbert, Arizona and 77 others

CompletedRegistry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsThis registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in…NCT02918539·Glendale, Arizona and 74 others

Completed18F-AV-1451 High Resolution Autopsy StudyThe study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.NCT02350634·Phoenix, Arizona and 1 other

TerminatedStudy Evaluating The Long-Term Safety And Efficacy Of Subcutaneous BapineuzumabThis study will evaluate the safety and tolerability of bapineuzumab when administered by subcutaneous injection.NCT00916617·Phoenix, Arizona and 15 others

CompletedSafety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's DiseaseThis study is being conducted to determine the safety and effect on cognitive function of the investigational medication, EVP-6124, in individuals with mild to moderate probable…NCT01073228·Phoenix, Arizona and 53 others

CompletedTreatment for Aggression and Agitation in Patients With Alzheimer's DiseaseThe purpose of this study is to determine whether this drug can help symptoms of aggression and agitation in participants with Alzheimer's disease.NCT00843518·Phoenix, Arizona and 16 others

TerminatedNuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's DiseaseThe primary objective of this study is to test the hypothesis that Nuedexta (20/10) administered orally will reduce Pseudobulbar Affect (PBA) frequency and severity (CNS-Lability…NCT01832350·Phoenix, Arizona

Active not recruitingA Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to…NCT07170150·Phoenix, Arizona and 146 others

Active not recruitingA Study of JNJ-64042056 in Participants With Preclinical Alzheimer's DiseaseThe purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to…NCT06544616·Phoenix, Arizona and 89 others

TerminatedOpen-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersThis is a Phase III, multicenter, open-label extension, single-group study in male and female outpatients with mild-to-moderate Alzheimer's disease (AD) who have completed either…NCT00490568·Litchfield Park, Arizona and 271 others

CompletedA Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabThis Phase II, open-label extension (OLE), multicenter study will evaluate the long-term safety and tolerability of crenezumab in participants with mild to moderate Alzheimer's…NCT01723826·Phoenix, Arizona and 85 others

TerminatedEvaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseaseThis is a study to evaluate the efficacy and safety of azeliragon in patients with mild Alzheimer's disease.NCT02080364·Phoenix, Arizona and 114 others

Page 1 of 13Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia